Home
About
Overview
Sharing Data
ORCID
Help
History (4)
CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling.
Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease.
Long-term safety of vedolizumab for inflammatory bowel disease.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term safety of vedolizumab for inflammatory bowel disease.
Long-term safety of vedolizumab for inflammatory bowel disease. Aliment Pharmacol Ther. 2020 10; 52(8):1353-1365.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal, Humanized
Cohort Studies
Colitis, Ulcerative
Crohn Disease
Drug-Related Side Effects and Adverse Reactions
Female
Follow-Up Studies
Gastrointestinal Agents
Humans
Inflammatory Bowel Diseases
Male
Middle Aged
Quality of Life
Time Factors
Treatment Outcome
Young Adult
authors with profiles
David Rubin